This fact sheet describes how the START-UP project is working with private-sector partners to develop two new tests that detect infection with the types of human papillomavirus (HPV) that cause cervical cancer. Designed for use in low-resource settings, these screening tools are an innovative answer to the challenge of early detection of the precursors of cervical cancer.

Publication date: July 2009

Region: Global

In low-resource settings, diabetes and tuberculosis are common among the same populations, and they amplify each other. PATH's principles and experiences guide our work in fighting these intersecting epidemics through innovation and collaboration.

Publication date: November 2012

Region: Global

This website about PATH’s Technology Solutions global program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2013

Region: Global

Part of series: PATH's program websites

This fact sheet provides an overview of PATH's work to adapt, design, develop, and advance health technologies to improve global health.

Publication date: December 2011

Region: Global

Part of series: PATH's areas of focus fact sheets

Demonstration of the use of a magnetic immunochromatographic strip (ICS) assay with a reader to detect recombinant HPV-16 E6. The magnetic ICS assay was able to detect as little as 2.6ng of protein. Presented at: 38th Annual Oak Ridge Conference, April 20, 2006; San Jose, CA.

Author: Peck R, Schweizer J, Weigl B, et al

Publication date: April 2006

Region: Global

This fact sheet from the Global Health Technologies Coalition examines how US leadership in global health research helps to saves lives worldwide and provides domestic economic benefits.

Publication date: March 2011

Region: North America and Europe

This document assesses the correspondence between retinol and retinol-binding protein (RBP), as well as the stability of RBP subjected to varying temperature conditions over time, the effect of light, and the feasibility of using dried blood spots. The assessment is part of a larger project examining the use of the RBP enzyme immunoassay (RBP-EIA) to test for vitamin A deficiency.

Publication date: 2006

Region: Africa

This document shares data from Guinea-Bissau that provide validation of the retinol-binding protein enzyme immunoassay (RBP-EIA) test from serum samples, while also providing initial data on the feasibility of using dried blood samples as a specimen type for the assessment of vitamin A deficiency in the field.

Publication date: 2006

Region: Africa